A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

References

• Serrano-Fujarte I, López-Romero E, Reyna-López GE, Martínez-Gámez MA, Vega-González A, Cuéllar-Cruz M. Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. Biomed Res Int. 2015;2015:1–15.
   Web of Science ®Google Scholar
• Deorukhkar SC, Saini S, and Mathew S. Non-albicans Candida Infection: an emerging threat. Interdiscip Perspect Infect Dis. 2014; ID 615958:1-8.
   Google Scholar
• Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Noverr MC. Candida albicans forms biofilms on the vaginal mucosa. Microbiology. 2010;156(Pt 12):3635–3644.
   PubMedGoogle Scholar
• Chandra J, Mccormick TS, Imamura Y, Mukherjee PK, Ghannoum MA. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun. 2007;75(5):2612–2620.
   PubMed Web of Science ®Google Scholar
• Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40(4):1244–1248.
   PubMed Web of Science ®Google Scholar
• Deorukhkar SC, Saini S, Mathew S. Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile. Int J Microbiol. 2014;2014:1–6.
   Google Scholar
• Tournu H, Dijck PV. Candida biofilms and the host: models and new concepts for eradication. Int J Med. 2011;2012: ID 845352:1–16.
   Google Scholar
• Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001;18(4):163–170.
   PubMedGoogle Scholar
• Tumbarello M, Posteraro B, Trecarichi EM, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol. 2007;45(6):1843–1850.
   PubMed Web of Science ®Google Scholar
• Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol. 2014;32(1):44–48.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Manchanda V, Verma N, Bhalla P. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol. 2011;29(2):172–177.
   PubMed Web of Science ®Google Scholar
• Melek I, Mustafa A, Ayse N. Investigation virulence factors of clinical Candida isolates in relation to atmospheric conditions and genotype. Turk J Med Sci. 2012;42(Supp 2):1476–1483.
   Google Scholar
• Swarna SR, Madhavan R, Gomathi S. A study of biofilm on diabetic foot ulcer. Int J Pharm Biomed Res. 2012;3(4):1809–1810.
   Google Scholar
• Matar MJ, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother. 2003;47(5):1647–1651.
   PubMed Web of Science ®Google Scholar
• Method for antifungal disk diffusion susceptibility testing of yeasts approved guideline. M44-A 2007; Vol. 24; No. 15.
   Google Scholar
• Tan TY, Tan AL, Tee NW, Ng LS. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Ann Acad Med Singapore. 2008;37(10):835–409.
   PubMed Web of Science ®Google Scholar
• Golia S, Hittinahalli V, Sangeetha KT et al. Study of biofilm formation as a virulence marker in Candida species isolated from various clinical specimens. JEMDS. 2012;1:1235–1246.
   Google Scholar
• Hasan F, Xess I, Wang X, Jain N, Fries BC. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect. 2009;11(8-9):753–761.
   PubMed Web of Science ®Google Scholar
• Tellapragada C, Eshwara VK, Johar R, et al. Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis. J Pathog. 2014;2014:1–8.
   Google Scholar
• Kaskatepe B, Yildiz S. Investigation of association between slime production by Candida species and susceptibility to fluconazole and voriconazole. Trop J Pharm Res. 2013;12(5):821–825.
   Web of Science ®Google Scholar
• Tumbarello M, Posteraro B, Trecarichi EM, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol. 2007;45(6):1843–1850.
   PubMed Web of Science ®Google Scholar
• Harakuni SU, Karadesai SG, Jamadar N. Biofilm production by Candida: comparison of bloodstream isolates with cervical isolates. Indian J Microbiol. 2012;52(3):504–506.
   PubMed Web of Science ®Google Scholar
• Paiva LC, Vidigal PG, Donatti L, Svidzinski TI, Consolaro ME. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics. Micron. 2012;43(2-3):497–502.
   PubMed Web of Science ®Google Scholar
• Bhatt M, Sarangi G, Paty BP, et al. Biofilm as a virulence marker in Candida species in Nosocomial blood stream infection and its correlation with antifungal resistance. Indian J Med Microbiol. 2015;33(Suppl):112–114.
   PubMedGoogle Scholar
• Han SS, Yim JJ, Yoo CG, et al. Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years. J Korean Med Sci. 2010;25(5):671–676.
   PubMed Web of Science ®Google Scholar